Rosenberg Javiera, Lampridou Smaragda, Moores Amelia, Garfield Sara, Wingfield David, Judah Gaby
Department of Surgery & Cancer, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, St. Mary's Hospital, London, UK.
Patient Prefer Adherence. 2025 Jan 4;19:29-48. doi: 10.2147/PPA.S502645. eCollection 2025.
Statins are effective in reducing cardiovascular disease (CVD) risk, but adherence rates remain low globally. Understanding and addressing modifiable influences on adherence is key to improving outcomes. Existing reviews have methodological limitations, often failing to integrate qualitative and quantitative data or consider specific barriers to statin adherence. This systematic review aimed to identify modifiable barriers and facilitators to statin adherence using the Theoretical Domains Framework (TDF). A comprehensive search of Embase, MEDLINE, PsycINFO, and CINAHL was conducted, covering studies from January 1998 to November 2023. Data were coded to TDF domains and synthesized to identify specific influences on adherence. The nature of the evidence (qualitative or quantitative) was recorded for each influence, and variations among patient groups were noted. Seventy studies from 20 countries were included, with only one focused on ethnic minorities. The most commonly identified domains affecting adherence were "Beliefs about Consequences", "Knowledge", 'Environmental Context and Resources', and "Social Influences". Key factors included knowledge of disease, perceived disease threat, perceived benefits of statins, and patient-provider communication and trust. While side effects had inconsistent associations with adherence, forgetfulness was mainly addressed in quantitative studies, and social influences were highlighted in qualitative research. This review identified modifiable factors that could improve statin adherence. Future research should focus on addressing barriers faced by underrepresented groups to create more inclusive and effective interventions that enhance patient support and communication for better health outcomes.
他汀类药物在降低心血管疾病(CVD)风险方面有效,但全球范围内的服药依从率仍然较低。了解并解决对依从性有影响且可改变的因素是改善治疗效果的关键。现有综述存在方法学上的局限性,常常未能整合定性和定量数据,也未考虑他汀类药物依从性的具体障碍。本系统综述旨在使用理论领域框架(TDF)确定影响他汀类药物依从性的可改变障碍和促进因素。对Embase、MEDLINE、PsycINFO和CINAHL进行了全面检索,涵盖1998年1月至2023年11月的研究。数据被编码到TDF领域并进行综合分析,以确定对依从性的具体影响。记录每种影响因素的证据性质(定性或定量),并注意不同患者群体之间的差异。纳入了来自20个国家的70项研究,其中只有一项关注少数民族。最常确定的影响依从性的领域是“对后果的信念”“知识”“环境背景和资源”以及“社会影响”。关键因素包括疾病知识、感知到的疾病威胁、他汀类药物的感知益处以及医患沟通与信任。虽然副作用与依从性的关联并不一致,但遗忘主要在定量研究中得到探讨,而社会影响则在定性研究中得到强调。本综述确定了可改善他汀类药物依从性的可改变因素。未来的研究应侧重于解决代表性不足群体所面临的障碍,以制定更具包容性和有效性的干预措施,加强患者支持与沟通,从而实现更好的健康结果。